[Experience in using helium-neon laser irradiation alone and in the combined therapy of myocardial infarct and other forms of IHD].
349 chronic sufferers from coronary heart disease (functional class II-IV) were exposed to He-Ne laser radiation, received alpha-tocopherol acetate, solcoseryl, mildronate. Alleviation of pain syndrome, quicker increase of exercise tolerance were observed in patients treated with combined regimens: i.v. laser radiation+alpha-tocopherol acetate, i.v. laser therapy+alpha-tocopherol acetate+solcoseryl. Solcoseryl proved efficient against arrhythmia, positive trends in lipid peroxidation were observed in the use of preradiation antioxidants. It is thought valid to use drug "protection" in laser therapy of CHD, especially in growing intensity of the exposure and power of the beam, to control parameters of coagulation, hemostasis, microcirculation and lipid peroxidation.